- Deltex Medical Group's revenue rose by 7% to £2.9m in the six months to the end of June and gross margins increased to 76% - up from 64% last time.

Operating cash costs were reduced by £0.3m to £2.9m and cash operating loss was reduced by 57% to £0.6m (H1 2016: £1.4m).

Net cash used in operating activities was £0.4m, £1.1m (73%) lower than in H1 2016 (£1.5m).

Chairman Nigel Keen said: "In the first half of 2017, Deltex Medical increased its sales, improved its margins and reduced its costs.

"We are therefore substantially on course to reach our key short-term objective of moving through the operating cash break-even point.

"The company entered the traditionally stronger second half with sales traction in its US and International businesses, a difficult but improved UK trend and the prospect of incremental returns from investments made in product development.

"The move from a single to a multiple technology platform increases significantly the company's marketing, commercial and strategic options."

Story provided by